News & Updates
Syphilis in Nevada and Updates to Nevada Administrative Code 441A
Background On Dec. 10, 2023, the Nevada Legislative Commission approved amendments to Nevada Administrative Code (NAC) 441A that updated syphilis testing, treatment and reporting guidelines for pregnant people to align...
STI Awareness Week 2024
More than 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported in 2022. CDC released the 2022 Sexually Transmitted Disease Surveillance report that provides the most current and complete data for...
Nevada 2023 Tuberculosis (TB) Fast Facts
The purpose of the Nevada 2023 Tuberculosis Disease (TB) Fast Facts report is to provide an analysis on all TB cases reported in 2023 in Nevada. This annual publication is...
Establishment of Central Nevada Health District and Communicable Disease Reporting
Summary The creation of the Central Nevada Health District (CNHD) is the result of four counties (Churchill, Mineral, Pershing and Eureka) and the City of Fallon seeking to provide local...
Electronic Reporting and Medical Facility Record Reporting
Background On Dec. 10, 2023, the Nevada Legislative Commission approved amendments to Nevada Administrative Code (NAC) 441A which updated the manner in which reports are received by health authorities and...
CDC Updated Respiratory Virus Guidance (including COVID-19)
Background1 On March 1, 2024, the Centers for Disease Control and Prevention (CDC) published updated guidance for respiratory virus illnesses, which includes COVID-19, influenza and RSV, among other common viral...
Laboratory Reporting Negative HIV and HEP C Tests
Summary On Dec. 10, 2023, the Nevada Legislative Commission approved amendments to the Nevada Administrative Code (NAC) 441A that updated reporting requirements for both hepatitis C virus (HCV) and human...
Updates to NAC 441A, Regarding Reportable Communicable Diseases in Nevada
Background On Dec. 10, 2023, the Nevada Legislative Commission approved amendments to Nevada Administrative Code (NAC) 441A that updated the conditions which are mandated to be reported in Nevada. These...
CDC Provides New Laboratory Recommendations for Syphilis Testing
Introduction Currently, no available nucleic acid amplification tests (NAATs) are cleared by Food and Drug Administration (FDA) for marketing in the United States to screen or diagnose syphilis, and culture...
Candida auris regulation changes
Background Candida auris (C. auris) is a newly emerging biological fungal agent that can cause severe illnesses. It is known to be resistant to most antifungal treatments and can spread...
Concerning Tuberculosis Trends and Guidance to Identify and Eliminate Tuberculosis
Summary of Concerning Tuberculosis Trends in Nevada To eliminate TB, Nevada’s public health systems in collaboration with health care providers need to increase identification of individuals at risk for TB,...
National Shortage of Erythromycin 0.5% Ophthalmic Ointment (erythromycin)
Gonorrhea ocular prophylaxis of newborns is mandated by law and is considered standard neonatal care in Nevada. Nevada Revised Statute (NRS) 442.050 and NRS 442.060 require every “physician or midwife...